v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:      
Net income $ 1,020,951 $ 897,556 $ 779,437
Adjustment to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 176,870 165,156 159,609
Amortization of right-of-use assets 39,339 32,406 34,232
Stock-based compensation costs (note 10) 80,184 71,142 65,257
Loss attributable to equity method investments, net of dividends received (note 6) 1,848 10,138 8,486
(Gain) loss on equity investments (note 6) 4,045 (9,922) 12,202
Restructuring expenses (note 18) 33,239 9,177 0
Gain on insurance recoveries 0 (20,227) 0
Changes in operating assets and liabilities:      
Accounts receivable (134,278) (106,511) 19,346
Inventories 172,203 (248,833) (311,681)
Prepaid expenses, net deferred income taxes and other current assets (115,213) (138,125) (168,109)
Accounts payable, accrued expenses and other 122,072 31,342 (247,632)
Net cash provided by operating activities 1,401,260 693,299 351,147
Cash flows from investing activities:      
Purchases of property, plant and equipment (99,460) (119,672) (134,835)
Patent registration costs (15,396) (14,328) (21,201)
Business acquisitions, net of cash acquired (133,464) (1,012,749) (42,784)
Purchases of investments (note 6) (12,765) (32,229) (20,724)
Proceeds from exits of investments (note 6) 1,000 3,937 6,802
Proceeds / (payments) on maturity of foreign currency contracts (9,699) 15,196 (17,176)
Net cash used in investing activities (269,784) (1,159,845) (229,918)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net 53,094 49,142 47,384
Taxes paid related to net share settlement of equity awards (8,757) (30,631) (52,406)
Purchases of treasury stock (150,011) 0 0
Payments of business combination contingent consideration (1,293) (2,361) 0
Proceeds from borrowings, net of borrowing costs 105,000 1,070,000 288,000
Repayment of borrowings (835,000) (405,000) (166,000)
Dividends paid (282,320) (258,276) (245,341)
Net cash (used in) provided by financing activities (1,119,287) 422,874 (128,363)
Effect of exchange rate changes on cash (1,719) (2,147) (14,434)
Net increase (decrease) in cash and cash equivalents 10,470 (45,819) (21,568)
Cash and cash equivalents at beginning of period 227,891 273,710 295,278
Cash and cash equivalents at end of period 238,361 227,891 273,710
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds 278,400 216,866 478,120
Interest paid 45,708 47,379 22,312
Fair value of assets acquired, excluding cash 46,033 359,730 15,648
Liabilities assumed (7,696) (131,765) (4,672)
Goodwill on acquisition 92,191 786,990 38,953
Previously held equity interest 0 0 (4,078)
Deferred payments (143) 2,542 (3,067)
Fair value of contingent consideration 4,372 (2,387) 0
Cash paid for acquisitions $ 134,757 $ 1,015,110 $ 42,784

Source

10-K PDF
XBRL